Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)
Claessens, Anouk K. M., Bos, Monique E. M. M., Lopez-Yurda, Marta, Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Honkoop, Aafke H., de Graaf, Hiltje, van Druten, Edith, van Warmerdam, Laurence J. C., van der Sangen, Maurice J. C., Tjan-Heijnen, Vivianne C. G., Erdkamp, Frans L. G.
Published in Breast cancer research and treatment (01.11.2018)
Published in Breast cancer research and treatment (01.11.2018)
Get full text
Journal Article
Cost-effectiveness of continuous versus intermittent chemotherapy for patients with HER2-negative advanced breast cancer
Claessens, Anouk K. M., Busschbach, Jan J. V., Ramaekers, Bram L. T., Erdkamp, Frans L. G., Bouma, Jeanette M., van Leeuwen-Stok, A. Elise, Tjan-Heijnen, Vivianne C. G., Bos, Monique E. M. M.
Published in Acta oncologica (04.05.2022)
Published in Acta oncologica (04.05.2022)
Get full text
Journal Article
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancer
Claessens, Anouk K. M., Erdkamp, Frans L. G., Lopez-Yurda, Marta, Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Honkoop, Aafke H., de Graaf, Hiltje, Tjan-Heijnen, Vivianne C. G., Bos, Monique E. M. M.
Published in Acta oncologica (02.06.2020)
Published in Acta oncologica (02.06.2020)
Get full text
Journal Article
The influence on quality of life of intermittent scheduling in first- and second-line chemotherapy of patients with HER2-negative advanced breast cancer
Claessens, Anouk K. M., Timman, Reinier, Busschbach, Jan J., Bouma, Jeanette M., Rademaker-Lakhai, Jeany M., Erdkamp, Frans L. G., Tjan-Heijnen, Vivianne C. G., Bos, Monique E. M. M.
Published in Breast cancer research and treatment (01.02.2020)
Published in Breast cancer research and treatment (01.02.2020)
Get full text
Journal Article
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)
Rovers, Koen P, Bakkers, Checca, Simkens, Geert A A M, Burger, Jacobus W A, Nienhuijs, Simon W, Creemers, Geert-Jan M, Thijs, Anna M J, Brandt-Kerkhof, Alexandra R M, Madsen, Eva V E, Ayez, Ninos, de Boer, Nadine L, van Meerten, Esther, Tuynman, Jurriaan B, Kusters, Miranda, Sluiter, Nina R, Verheul, Henk M W, van der Vliet, Hans J, Wiezer, Marinus J, Boerma, Djamila, Wassenaar, Emma C E, Los, Maartje, Hunting, Cornelis B, Aalbers, Arend G J, Kok, Niels F M, Kuhlmann, Koert F D, Boot, Henk, Chalabi, Myriam, Kruijff, Schelto, Been, Lukas B, van Ginkel, Robert J, de Groot, Derk Jan A, Fehrmann, Rudolf S N, de Wilt, Johannes H W, Bremers, Andreas J A, de Reuver, Philip R, Radema, Sandra A, Herbschleb, Karin H, van Grevenstein, Wilhelmina M U, Witkamp, Arjen J, Koopman, Miriam, Haj Mohammad, Nadia, van Duyn, Eino B, Mastboom, Walter J B, Mekenkamp, Leonie J M, Nederend, Joost, Lahaye, Max J, Snaebjornsson, Petur, Verhoef, Cornelis, van Laarhoven, Hanneke W M, Zwinderman, Aeilko H, Bouma, Jeanette M, Kranenburg, Onno, van 't Erve, Iris, Fijneman, Remond J A, Dijkgraaf, Marcel G W, Hemmer, Patrick H J, Punt, Cornelis J A, Tanis, Pieter J, de Hingh, Ignace H J T
Published in BMC cancer (25.04.2019)
Published in BMC cancer (25.04.2019)
Get full text
Journal Article